Chronic hepatitis B is one of the world's leading causes of liver cancer, yet many people do not know they are living with the disease. As a "silent disease", chronic hepatitis B can go unnoticed for years while ongoing liver inflammation leads to scarring and increases the risk of serious liver complications. In this clip, Joyeta Das, our Senior Global Medical Director for Hepatitis B, explains the substantial burden chronic hepatitis B places on individuals and healthcare systems, and why continued awareness of the disease matters. Listen to our full podcast episode to hear more from Joyeta, Dr Kat Arney and Jessica Hicks, Senior Director at the The World Hepatitis Alliance, as they explore the impact of chronic hepatitis B, the importance of awareness and the challenges that remain for people living with the disease. 🎧 Available on all your favourite podcast platforms: https://gsk.to/48jDXNz #TLM26 #BTSPodcast
Not enough history yet to show a trend.